CERO

insider transactions

CERO THERAPEUTICS HOLDINGS, INC. — buys & sells by directors, officers and 10% owners (SEC Form 4).

30D 90D 1Y

No open-market buys or sells this period. The trades below are grants, option exercises and gifts, which carry no market price.

Net buy / sell volume

Tap or hover the chart for daily net volume. Green = net buying, red = net selling.

All transactions

Grant·A
Mar 4, 26

Eric Francois

Director

$0

1.8M sh

Own New
Grant·A
Jan 7, 26

Christopher B Ehrlich KEY

Chairman and CEO

$0

4.5M sh

Own New
Grant·A
Jan 7, 26

Lindsey Rolfe

Director

$0

690.9K sh

Own New
Grant·A
Jan 7, 26

Andrew Albert Kucharchuk KEY

Chief Financial Officer

$0

1.2M sh

Own New
Grant·A
Jan 7, 26

Kathleen Laporte

Director

$0

690.9K sh

Own New
Grant·A
Jan 7, 26

Shami Patel

Director

$0

690.9K sh

Own New
Grant·A
Jan 7, 26

Kristen Pierce

Chief Development Officer

$0

1.6M sh

Own New
Grant·A
Jan 7, 26

Michael Byrnes

Director

$0

690.9K sh

Own New
Grant·A
Jan 7, 26

Brian G Atwood

Director

$0

1.6M sh

Own New

Date▾	Insider	Role	Type	Shares	Own Δ	Price	Value
Mar 4, 2026	Eric Francois	Director	Grant A	1.8M	New	—	$0
Jan 7, 2026	Christopher B Ehrlich KEY	Chairman and CEO	Grant A	4.5M	New	—	$0
Jan 7, 2026	Lindsey Rolfe	Director	Grant A	690.9K	New	—	$0
Jan 7, 2026	Andrew Albert Kucharchuk KEY	Chief Financial Officer	Grant A	1.2M	New	—	$0
Jan 7, 2026	Kathleen Laporte	Director	Grant A	690.9K	New	—	$0
Jan 7, 2026	Shami Patel	Director	Grant A	690.9K	New	—	$0
Jan 7, 2026	Kristen Pierce	Chief Development Officer	Grant A	1.6M	New	—	$0
Jan 7, 2026	Michael Byrnes	Director	Grant A	690.9K	New	—	$0
Jan 7, 2026	Brian G Atwood	Director	Grant A	1.6M	New	—	$0

About CERO insider trading

This page tracks insider transactions for CERO THERAPEUTICS HOLDINGS, INC. (CERO) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.